COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 3058: Articles 30571-30580  | Next

ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
Lu, J., Hu, S., Fan, R., Liu, Z., Yin, X., Wang, Q., Lv, Q., Cai, Z., Li, H., Hu, Y., Han, Y., Hu, H., Gao, W., Feng, S., Liu, Q., Li, H., Sun, J., Peng, J., Yi, X., Zhou, Z., Guo, Y., Hou, J.
10.1101/2020.02.20.20025510 — Posted: 2020-02-23
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China
Yuan, M., Yin, W., Tao, Z., Tan, W., Hu, Y.
10.1101/2020.02.22.20024927 — Posted: 2020-02-23
Effectiveness of intervention strategies for Coronavirus Disease 2019 and an estimation of its peak time
pan, j., yao, y., liu, z., li, m., wang, y., dong, w., kan, h., wang, w.
10.1101/2020.02.19.20025387 — Posted: 2020-02-23
A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention
Lu, H., Ai, J., Shen, Y., Li, Y., Li, T., Zhou, X., Zhang, H., Zhang, Q., Ling, Y., Wang, S., Qu, H., Gao, Y., Li, Y., Yu, K., Zhu, D., Zhu, H., Tian, R., Zeng, M., Li, Q., Song, Y., Li, X., Xu, J., Xu, J., Mao, E., Hu, B., Li, X., Zhu, L., Zhang, W.
10.1101/2020.02.19.20025031 — Posted: 2020-02-23
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study
Zhang, J., Litvinova, M., Wang, W., Wang, Y., Deng, X., Chen, X., Li, M., Zheng, W., Yi, L., Chen, X., Wu, Q., Liang, Y., Wang, X., Yang, J., Sun, K., Longini, I. M., Halloran, M. E., Wu, P., Cowling, B. J., Merler, S., Viboud, C., Vespignani, A., Ajelli, M., Yu, H.
10.1101/2020.02.21.20026328 — Posted: 2020-02-23
Comparative study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting uncontrolled inflammation might not be the main reason of tissue injury
Zheng, Y., Huang, Z., Ying, G., Zhang, X., Ye, W., Hu, Z., Hu, C., Wei, H., Zeng, Y., Chi, Y., Cheng, C., Lin, F., Lu, H., Xiao, L., Song, Y., Wang, C., Yi, Y., Dong, L.
10.1101/2020.02.19.20024885 — Posted: 2020-02-23 Discussion: Onsite | Offsite
From Isolation to Coordination: How Can Telemedicine Help Combat the COVID-19 Outbreak?
Zhai, Y., Wang, Y., Zhang, M., Gittell, J. H., Jiang, S., Chen, B., Cui, F., He, X., Zhao, J., Wang, X.
10.1101/2020.02.20.20025957 — Posted: 2020-02-23
The role of institutional trust in preventive and treatment-seeking behaviors during the 2019 novel coronavirus (2019-nCoV) outbreak among residents in Hubei, China
Wong, L. P., Wu, Q. h., Chen, X., Chen, Z., Alias, H., Shen, M., Hu, J. c., Duan, S., Zhang, J. j., Han, L.
10.1101/2020.02.15.20023333 — Posted: 2020-02-21
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
Thao, T. T. N., Labroussaa, F., Ebert, N., V'kovski, P., Stalder, H., Portmann, J., Kelly, J., Steiner, S., Holwerda, M., Kratzel, A., Gultom, M., Laloli, L., Huesser, L., Wider, M., Pfaender, S., Hirt, D., Cippa, V., Crespo-Pomar, S., Schroeder, S., Muth, D., Niemeyer, D., Mueller, M. A., Drosten, C., Dijkman, R., Jores, J., Thiel, V.
10.1101/2020.02.21.959817 — Posted: 2020-02-21 Discussion: Onsite | Offsite
Functional pangenome analysis provides insights into the origin, function and pathways to therapy of SARS-CoV-2 coronavirus
Alam, I., Kamau, A. K., Kulmanov, M., Arold, S. T., Pain, A. T., Gojobori, T., Duarte, C. M.
10.1101/2020.02.17.952895 — Posted: 2020-02-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).